Influence of prenylamine on the cardiovascular effects of tyramine, noradrenaline and adrenaline in man

[1]  D. Palm,et al.  On the metabolism of prenylamine (segontin®) , 1968, Experientia.

[2]  H. Kuschke,et al.  Zum Wirkungsmechanismus des Phenylpropyl-diphenylpropylamins (Segontin) beim Menschen , 1965, Klinische Wochenschrift.

[3]  F. Sjöqvist,et al.  Tyramine pressor effects in man before and during treatment with nortriptyline or ECT: Correlation between plasma level and effect of nortriptyline , 1970, Pharmacologia Clinica.

[4]  W. Niedermayer,et al.  Der Einfluß von Prenylamin (Segontin®) auf die cardiovasculären Wirkungen von tyramin , 1968, Pharmacologia Clinica.

[5]  J. Vane,et al.  Interaction of the effects of tyramine, amphetamine and reserpine in man , 1962, Psychopharmacologia.

[6]  H. Grobecker,et al.  Fluorescenzmikroskopische Untersuchungen über die Wirkung des Prenylamins auf noradrenergische Nerven , 2004, Naunyn-Schmiedebergs Archiv für Pharmakologie und experimentelle Pathologie.

[7]  P. Holtz,et al.  Zur Pharmakologie des Prenylamins , 2004, Naunyn-Schmiedebergs Archiv für Pharmakologie und experimentelle Pathologie.

[8]  H. Fengler,et al.  Metabolisierung von Prenylamin (Segontin®) , 2004, Naunyn-Schmiedebergs Archiv für Pharmakologie und experimentelle Pathologie.

[9]  A. Carlsson.  Recent studies on the mode of action of antidepressive drugs , 2004, Naunyn-Schmiedebergs Archiv für Pharmakologie und experimentelle Pathologie.

[10]  D. Palm,et al.  Adrenergic and “antiadrenergic” actions of prenylamine , 2004, Naunyn-Schmiedebergs Archiv für Pharmakologie und experimentelle Pathologie.

[11]  M. Eichelbaum,et al.  Untersuchungen zum Verhalten von C14-d,l-Prenylamin im Organismus , 2004, Naunyn-Schmiedebergs Archiv für Pharmakologie und experimentelle Pathologie.

[12]  D. Palm,et al.  Urinary excretion of amphetamine in man after administration of prenylamine. , 1969, Life sciences.

[13]  J. Tasson,et al.  Influence of prenylamine on the excretion of catecholamines and metabolites in man during exercise. , 1969, European journal of pharmacology.

[14]  B. May,et al.  Über die Wirkung von Pharmaka auf den Brenzkatechinaminstoffwechsel , 1969 .

[15]  M. Youdim,et al.  The effect of tyramine, reserpine and other drugs on catecholamine metabolism in man. , 1968, British journal of pharmacology.

[16]  A. Shum,et al.  The influence of orally administered prenylamine on the storage and excreti catecholamines in humans and rats. , 1968, Archives internationales de pharmacodynamie et de therapie.

[17]  M. Youdim,et al.  Promotion of 4-Hydroxy-3-methoxy-phenylglycol Formation in Man by Reserpine , 1968, Nature.

[18]  J. Oates,et al.  Antagonism of the antihypertensive action of guanethidine sulfate by desipramine hydrochloride. , 1967, JAMA.

[19]  F. Lee.  The relation between norepinephrine content and response to sympathetic nerve stimulation of various organs of cats pretreated with reserpine. , 1967, The Journal of pharmacology and experimental therapeutics.

[20]  L. Iversen.  The Uptake and Storage of Noradrenaline in Sympathetic Nerves , 1967 .

[21]  E. Braunwald,et al.  F. SYMPATHETIC ACTIVITY AND NEUROTRANSMITTER DEPLETION IN CONGESTIVE HEART FAILURE , 1966 .

[22]  J. Axelrod.  Methylation reactions in the formation and metabolism of catecholamines and other biogenic amines. , 1966, Pharmacological reviews.

[23]  I. Kopin.  Biochemical aspects of release of norepinephrine and other amines from sympathetic nerve endings. , 1966, Pharmacological reviews.

[24]  A. Carlsson.  Drugs which block the storage of 5-hydroxytryptamine and related amines , 1966 .

[25]  A. Carlsson.  PHYSIOLOGICAL AND PHARMACOLOGICAL RELEASE OF MONOAMINES IN THE CENTRAL NERVOUS SYSTEM , 1966 .

[26]  E. Braunwald,et al.  Sympathetic activity and neurotransmitter depletion in congestive heart failure. , 1966, Pharmacological reviews.

[27]  M. Sandler,et al.  The estimation of 4-hydroxy-3-methoxyphenylglycol and total metadrenalines in human urine , 1965 .

[28]  A. Carlsson,et al.  Inhibition of 3H‐metaraminol uptake by antidepressive and related agents , 1965, The Journal of pharmacy and pharmacology.

[29]  H. Rauen,et al.  [THE EXCRETION OF 3-METHOXY-4-HYDROXYMANDELIC ACID IN MAN AFTER SEGONTIN ADMINISTRATION]. , 1964, Klinische Wochenschrift.

[30]  F. Abboud,et al.  Effects of Small Oral Doses of Reserpine on Vascular: Responses to Tyramine and Norepinephrine in Man , 1964, Circulation.

[31]  H. Kuschke,et al.  Untersuchungen über den Wirkungsmechanismus des Phenylpropyl-diphenylpropyl-amin (Segontin) beim Menschen , 1964 .

[32]  A. Sjoerdsma,et al.  Enhancement by Methyldopa of Tyramine Sensitivity in Man , 1963, Nature.

[33]  U. Trendelenburg.  Supersensitivity and subsensitivity to sympathomimetic amines. , 1963, Pharmacological reviews.

[34]  W. Mahon,et al.  THE PRESSOR EFFECT OF TYRAMINE IN MAN AND ITS MODIFICATION BY RESERPINE PRETREATMENT. , 1963, The Journal of clinical investigation.

[35]  J. Häggendal.  Fluorimetric determination of 3-O-methylated derivatives of adrenaline and noradrenaline in tissues and body fluids. , 1962 .

[36]  U. Trendelenburg,et al.  Effect of tyramine on isolated guinea-pig atria in relation to their noradrenaline stores. , 1962, British journal of pharmacology and chemotherapy.

[37]  J. Pisano,et al.  Determination of 3-methoxy-4-hydroxymandelic acid in urine. , 1962, Clinica chimica acta; international journal of clinical chemistry.

[38]  R. Knight,et al.  The determination of 3-methoxy 4-hydroxy mandelic acid in urine , 1961, Journal of clinical pathology.

[39]  U. S. Euler,et al.  Improved technique for the fluorimetric estimation of catecholamines. , 1961, Acta physiologica Scandinavica.

[40]  H. Taussky,et al.  A procedure increasing the specificity of the Jaffe reaction for the determination of creatine and creatinine in urine and plasma. , 1956, Clinica chimica acta; international journal of clinical chemistry.

[41]  H. Weissbach,et al.  The identification of 5-hydroxy-3-indoleacetic acid in normal urine and a method for its assay. , 1955, The Journal of biological chemistry.